“A comprehensive series of non-GLP and GLP studies have been conducted. The program included tissue cross-reactivity studies in panels of human tissues and IV toxicology studies of up to 13 treatment cycles (13 weeks duration) performed in cynomolgus monkeys.”
✓ VerifiedFDA multi-discipline review, p. 43Source ↗
Pivotal GLP studies
GLP cynomolgus 13-week weekly IV infusion study (8-week interim, 8-week recovery), 5/50/150 mg/kg
“Doses of 0 (vehicle control), 5, 50, and 150 mg/kg QW Route of administration: 1 hour IV infusion Formulation/Vehicle: sucrose, pH Species/Strain: Cynomolgus monkey”
✓ VerifiedFDA multi-discipline review, p. 44Source ↗
Route in tox
IV infusion
“Intravenous dosing was utilized in all pivotal toxicology studies since it is the intended route of administration in the clinic.”
✓ VerifiedFDA multi-discipline review, p. 43Source ↗